Uneingeschränkter Zugang

Virtual modelling of novel applicator prototypes for cervical cancer brachytherapy

Primoz Petric

Primoz Petric

Suche nach diesem Autor auf
Sciendo|Google Scholar
Petric, Primoz
, 
Robert Hudej

Robert Hudej

Suche nach diesem Autor auf
Sciendo|Google Scholar
Hudej, Robert
, 
Noora Al-Hammadi

Noora Al-Hammadi

Suche nach diesem Autor auf
Sciendo|Google Scholar
Al-Hammadi, Noora
 und 
Barbara Segedin

Barbara Segedin

Suche nach diesem Autor auf
Sciendo|Google Scholar
Segedin, Barbara
  
09. Nov. 2016
Virtual modelling of novel applicator prototypes for cervical cancer brachytherapy's Cover Image
Über diesen Artikel
Vorheriger Artikel
Nächster Artikel
Zitieren
COVER HERUNTERLADEN
Artikel-Kategorie: Research Article
Online veröffentlicht: 09. Nov. 2016
Seitenbereich: 433 - 441
Eingereicht: 01. Juli 2016
Akzeptiert: 29. Aug. 2016
DOI: https://doi.org/10.1515/raon-2016-0048
Schlüsselwörter
© 2016 Radiol Oncol
This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Principles of Target-volume Density Map (TDM) generation and postprocessing on an example of 6 cervical cancer cases. (A) Contours of high risk clinical target volumes (CTVHR – thin white lines) are shown on mid-coronal T2 weighted MRI with the applicator in place. Source channels are depicted as thick white lines. (B) CAT 2 generates the TDM by rigid co-registration of individual CTVHRs on a reference applicator. TDM voxels are assigned target density values, corresponding to the number of encompassing CTVHRs. These values are transformed to grey levels. (C) Resulting TDM DICOM image is exported to treatment planning system where isodensity contours (IDC) are auto-segmented (white dotted lines).
Principles of Target-volume Density Map (TDM) generation and postprocessing on an example of 6 cervical cancer cases. (A) Contours of high risk clinical target volumes (CTVHR – thin white lines) are shown on mid-coronal T2 weighted MRI with the applicator in place. Source channels are depicted as thick white lines. (B) CAT 2 generates the TDM by rigid co-registration of individual CTVHRs on a reference applicator. TDM voxels are assigned target density values, corresponding to the number of encompassing CTVHRs. These values are transformed to grey levels. (C) Resulting TDM DICOM image is exported to treatment planning system where isodensity contours (IDC) are auto-segmented (white dotted lines).
Schematic representation of applicator modelling based on our theoretical example of Target-volume Density Map (TDM). Above: Three virtual applicators are reconstructed on the TDM. Dose distribution is optimized based on a set of specific planning aims for the isodensity contours (IDC) and for residual volumes at risk (RVR). The optimized prescription isodoses for individual applicators are shown as thick dotted lines. (A) Standard intracavitary applicator: limited possibility for optimization. The planning aim is achieved for ≈70% IDC. (B) Combined intracavitary and interstitial applicator with parallel parametrial needles (Vienna-type): planning aim is achieved for ≈95% IDC. (C) Combined intracavitary and interstitial applicator with parallel and oblique parametrial needles: planning aim as achieved for ≈100 % IDC. (D) Characteristic curves for the IDC of the three applicator types. RVR curves are not shown. Shaded areas under characteristic curves represents IDC ranges in which certain applicator is able to achieve the planning aim. Arbitrary planning aim and applicator thresholds are marked by dotted lines.
Schematic representation of applicator modelling based on our theoretical example of Target-volume Density Map (TDM). Above: Three virtual applicators are reconstructed on the TDM. Dose distribution is optimized based on a set of specific planning aims for the isodensity contours (IDC) and for residual volumes at risk (RVR). The optimized prescription isodoses for individual applicators are shown as thick dotted lines. (A) Standard intracavitary applicator: limited possibility for optimization. The planning aim is achieved for ≈70% IDC. (B) Combined intracavitary and interstitial applicator with parallel parametrial needles (Vienna-type): planning aim is achieved for ≈95% IDC. (C) Combined intracavitary and interstitial applicator with parallel and oblique parametrial needles: planning aim as achieved for ≈100 % IDC. (D) Characteristic curves for the IDC of the three applicator types. RVR curves are not shown. Shaded areas under characteristic curves represents IDC ranges in which certain applicator is able to achieve the planning aim. Arbitrary planning aim and applicator thresholds are marked by dotted lines.
Sprache:
Englisch
Zeitrahmen der Veröffentlichung:
4 Hefte pro Jahr
Fachgebiete der Zeitschrift:
Medizin, Klinische Medizin, Allgemeinmedizin, Innere Medizin, Hämatologie, Onkologie, Radiologie
Zeitschrift RSS Feed